Poster Session Information
Total Page:16
File Type:pdf, Size:1020Kb
POSTER PRESENTATIONGuidelines OVERVIEW Poster sessions are designed to give presenters an opportunity to discuss informally their research with colleagues interested in their research. The purpose of the posters is to visually stimulate interest in the research, to present sufficient information for view- 21st ers to understand the methods, results, and signifi- cance of the research, and to promote conversations and networking among conference participants. ICPE August 21-24, 2005 POSTER SESSION Gaylord Opryland Resort and Convention Posters will be displayed in Ryman Exhibit Hall. Each session is for one day: Center, Nashville, TN Monday, August 22, Poster Session A Tuesday, August 23, Poster Session B NUMBERING SYSTEM Wednesday, August 24, Poster Session C Each poster board will be numbered. The poster number is the first number listed. 1. Set Up Presenters should attach their posters to the 7:00am-8:15am. All posters must be up by 8:15am. board number corresponding to the number assigned to their poster in the final program, 2. Open which will be available at the registration Ryman Exhibit Hall will be open from: desk. Please note the number may differ from 7:00am - 5:00pm, Monday and Tuesday, and that shown in the preliminary program. The 7:00am -1:30pm Wednesday. abstract number, for use in locating abstracts in the final program and the special issue of All food functions (continental breakfasts, breaks Pharmacoepidemiology and Drug Safety, is in and lunches) as well as exhibits will be located brackets [xxx] after the title of the abstract. in Ryman Exhibit Hall. POSTER SPECIFICATIONS 3. Discussion Time 1. Posters must be designed to fit a space 4 Presenters should be at their poster between feet high by 8 feet wide. Vertical posters 12:15-1:15pm to discuss their posters with will not fit the boards; only horizontal interested viewers. posters are allowed. The board will be the only support device available. Business 4. Take Down cards or small leaflet literature for distribu- All posters must be taken down by 6:00 pm on tion may be inserted in an envelope and Monday and Tuesday; posters must be taken affixed to the board. Poster orientation: down by 2:00pm on Wednesday. Landscape. NOTE: Neither ISPE or the Opryland Resort & 2. Posters may be attached to the boards by Convention Center will be responsible for any poster pushpins or male Velcro. Please bring your that is left up overnight or is lost or damaged. own mounting supplies. 27 August 21-24, 2005 | Gaylord Opryland Resort and Convention Center | Nashville, TN POSTER SESSION A | MONDAY, AUGUST 22, 2005 1 Non-Steroidal Anti-Inflammatory 10 Survey of Disability, Medication Use, and 20 Incidence and Prevalence of Medication: Do Medical Records Agree Medication Satisfaction among Members Antipsychotic Use in Non- with Patient Self Report? [1] with Rheumatoid Arthritis of a Large Institutionalised Patients in 1993-2003 Maziar Abdolrasulnia, Nelson Weichold, Health Care Plan Database [10] [20] Linda L Casebeer, Norm W Weissman, P Mona Eng, Catherine B Johannes, Claire C Gerard WK Hugenholtz, Eibert R Heerdink, Kenneth G Saag, Jeroan Allison. (United Chaing, William A West, John D Seeger, Willem A Nolen, Toine CG Egberts. States) Alexander M Walker. (United States) (Netherlands) 2 Detection and Treatment of Hypertension 11 The Influence of Environmental 21 Monitoring of Vaccine Safety Inquiries: A in General Health Care Practice. A Temperature on Lithium Serum Levels [11] New Tool for Vaccine Safety Signal Patient-Based Study [2] Sandra Fase, Ingeborg Wilting, Eibert R Generation [21] Ahmad Al-Windi. (Sweden) Heerdink, Willem A Nolen, Toine CG Elaine R Miller, John K Iskander, Penina Egberts. (Netherlands) Haber, Paul Gangarosa, Vitali Pool, Robert T 3 Patterns of Discontinuation, Dose Chen. (United States) Modification and Switching among Users 12 A Study of the Use of Cisapride Analyzed of Prescription Non-Steroidal Anti- from the Claim Database of National 22 Utilization Patterns of Pharmaceutical Inflammatory Drugs (NSAID) Including Health Insurance Program in Taiwan [12] and Herbal Medicine in Pregnancy and Cyclo-Oxygenase 2 Inhibitors (COX-2) in Churn-Shiouh Gau, I-Shou Chang, Fei-Lin Lactation [22] a UK Population [3] Lin Wu, Hui-Tzu Yu, Yu-Wen Huang, Cheng- Sigal Kaplan, Sheila Weiss Smith. (United Felix M Arellano, Charles E Wentworth, Liang Chi, Su-Yu Chien, Keh-Ming Lin, Hui- States) Corey May, Anila Verma, Javier Cid. (United Po Wang. (Taiwan) States) 23 Association of Dual Use of Over-the- 13 Comparative Safety of Colloids: Results of a Counter and Prescription Non-Steroidal 4 The International Diabetes Management Disproportionality Analysis (DA) [13] Anti-Inflammatory Drugs (NSAIDs) with Practices Study (IDMPS): Methodology Manfred Hauben, Charles M Gerrits, Lester Health-Related Quality of Life [23] and First Results of the Pilot Study [4] Reich. (United States) Stacey H Kovac, Kenneth G Saag, Jeffrey R Cecile Beden, Pablo Aschner, Juan Jose Curtis, Jeroan Allison. (United States) Gagliardino, Nicolae Hancu, Patrick 14 Comparative Performance of Proportional Sinassamy. (France) Reporting Ratios (PRR) and Multi-Item 24 Impact of Consumer-Initiated Adverse Gamma Poisson Shrinker (MGPS) for the Event Reports on Case Volume and Report 5 Regional Differences in Suicide Rate and Identification of Crystalluria and Urinary Source Distribution [24] Use of Lithium in Norway [5] Tract Calculi Caused by Drugs [14] Ed Keystone, Haiying Liu, Atsuko Shibata, Jorgen G Bramness, Fredrik Walbye, Manfred Hauben, Lester Reich, Charles M Wayne Wallis, Sean Zhao. (United States) Svetlana Skurtveit, Aa Tverdal. (Norway) Gerrits. (United States) 25 A Systematic Review and Critical 6 A Contribution to the Rational Use of 15 Prevalence of Osteoarthritis and Evaluation of Risk-Benefit Analysis Contraceptive Methods among Female Rheumatoid Arthritis: Cross-Sectional Methods for Therapeutic Interventions Adolescent Students in Campo Grande, Analysis in a Follow up Study [15] [25] MS, Brazil [6] Antonio González-Pérez, Luis A García Larry D Lynd, Mark J Sculpher, Andrew R Valdir S Siroma, Lia LC Castro. (Brazil) Rodríguez, Saga Johansson, Mari-Ann Willan, Megan E Coombes. (Canada) Wallander. (Spain) 7 Making Medical Injection Safer: A Major 26 Healthcare Spending and Use for the Top Step towards Enhancing Patient Safety in 16 Drug Utilization and Market-Share 5 Conditions among United States Developing Countries [7] Competition among Antipsychotics in US Community Dwelling Adults: Findings Robert T Chen, Glenn Post, Jules Millogo, Medicaid Programs [16] from the Medical Expenditure Panel Karen Van Roekel, Mary Catlin, Ken Clark. Jeff J Guo, Christine ML Kelton, Yan Chen, Surveys 1997-1998 and 2000-2001 [26] (United States) Yonghua Jing, Nick Patel. (United States) Margaret McDonald, Robin P Hertz, Alan N Unger, Michael B Lustik, Jeffrey A Cornell. 8 Association of Caffeine Concentrations 17 Consumers Usurp Spontaneous Adverse (United States) with Fasting Glucose Levels in Caffeine- Event Reporting in the United States [17] Drug Users and Nonusers — Results of Isaac W Hammond, Donna Rich. (United 27 Antihypertensive Medication Use in German National Health Surveys from States) Newly-Aware Hypertensives [137] 1984 to 1999 [8] C Ineke Neutel, Norm Campbell, Lisa Yong Du, Hans-Ulrich W Melchert, Hildtraud 18 Quality of Data Provided to Physicians by Pogany, Leslie Gaudette (Canada) Knopf, Ellen Pabel. (Germany) Dietary Supplement Manufacturers in Support of Safety and Efficacy Claims [18] 28 What Is the Justification for Long-Term 9 Antidepressant Use during Pregnancy and David J Hass, James D Lewis. (United States) Benzodiazepine Use? [28] Potential Neonatal Adverse Effects: Impact C Ineke Neutel (Canada) of a Health Canada Advisory and 19 Cardiovascular Risk Factors at Baseline Subsequent Reports in the News Media [9] and Cardiovascular Events in Patients 29 Social Circumstances Adverse Event Terms Adrienne Einarson, Anne-Marie with Metastatic Breast Cancer Receiving in MedDRA: Extent of Coding and Potential Schachtschneider, Roland Halil, Enkelejde Hormone- or Chemotherapy [19] Impact on Signal Detection [29] Bollano, Koren Gideon. (Canada) Nancy S Breekveldt-Postma, Myrthe Sukel, Manfred Hauben, Vaishali K Patadia. Joëlle A Erkens, Annette B Beiderbeck, Ron (United States) MC Herings. (Netherlands) 28 21st ICPEInternational Conference on Pharmacoepidemiology & Therapeutic Risk Management POSTER SESSION A | MONDAY, AUGUST 22, 2005 30 Potentially Inappropriate Prescribing for 41 Prevalence and Factors Associated with 50 Effectiveness of Antipsychotic Older Veterans: The Impact of Healthcare the Offlabel Use of Antipsychotic, Treatments in a Nation-Wide Cohort of System Factors [30] Antidepressant and Anticonvulsant 2230 Patients in Community Care after Mary Jo V Pugh, B Graeme Fincke, Arlene Medications among Georgia Medicaid the First Hospitalization Due to Bierman, Francesca Cunningham, Dan R Eligibles in 2001 [41] Schizophrenia and Schizoaffective Berlowitz. (United States) Hua Chen, Bradley C Martin. (United States) Disorder [50] Jari K Haukka, Jari Tiihonen, Timo Klaukka, 31 Pregnancy Registries: Streamlining 42 Use of Propensity Scores To Identify Kristian Wahlbeck, Jouko Lönnqvist. (Finland) Regulatory Requirements To Increase Possible Medication Dispensing Errors Enrollment [31] among Patients with Alzheimer’s Disease 51 Retrospective Cohort Study on Relationship Susan S Roberts, Deborah L Covington, [42] between Short-Term Fever of Unexplained Peggy A Doi. (United